Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT04026412
A Phase 3, Randomized, Open Label Study to Compare Nivolumab plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Durvalumab in Previously Untreated, Locally Advanced Non-small Cell Lung Cancer (LA NSCLC)
Status
Open (affiliates only)
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Vu, John
Practice
Lung
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04026412
Secondary Trial ID Number
CA209-73L
Keywords
Treatment